Parkinson's disease Board decisions

The Veteran's combined disability rating for Parkinson's disease and its manifestations is 100 percent, and special monthly compensation at the rate set forth in 38 U.S.C. § 1114(r)(1) is granted.

The Board remands the case to ensure all necessary efforts are made to verify the Veteran's claimed exposure to herbicides aboard the USS Oriskany.

The Board granted an effective date of November 20, 2018, for the awards of increased ratings to 50 percent for left upper extremity involvement and 40 percent for right upper extremity involvement associated with Parkinson's disease.

The Board granted an effective date of February 8, 2022, for the grant of service connection for Parkinson's Disease based on continuous pursuit and evidence of symptoms prior to formal diagnosis.

The Board granted service connection for chronic lymphocytic leukemia, coronary artery disease with atrial fibrillation, diabetes mellitus type II, and Parkinson's disease based on presumptive service connection due to herbicide exposure.

The Board granted service connection for diabetes mellitus, coronary artery disease (CAD), and Parkinson's disease based on herbicide exposure during the Veteran's service.

The veteran withdrew his appeal seeking increased ratings for various conditions, including peripheral neuropathy and non-alcoholic steatohepatitis.

The Board denied service connection for the Veteran's cause of death, specifically Parkinson's disease and Parkinson's dementia, as there was no evidence to support that these conditions were related to the Veteran's military service.

The Board granted service connection for bipolar type schizoaffective disorder in sustained remission with severe recurrent major depressive disorder, resolving reasonable doubt in favor of the Veteran.

The Board granted service connection for hypertension, Parkinson's disease, cryptococcal infection, and sarcoidosis as secondary to the cryptococcal infection. COPD was also granted as secondary to both cryptococcal infection and Parkinson's disease.

The Board granted service connection for diabetes mellitus Type II, hypertension, bilateral femoral stents for peripheral vascular disease (PVD), and heart disability, but denied service connection for Parkinson's disease.

The Board remands the case to obtain new medical opinions regarding the Veteran's cause of death, specifically addressing his service in the Panama Canal Zone and potential exposure to toxins.

The Board granted service connection for Parkinson's disease, an acquired psychiatric disorder (depression and anxiety) as secondary to Parkinson's disease, and degenerative arthritis, lumbosacral strain with history of lumbar laminectomies, and bilateral radiculopathies as secondary to Parkinson's disease.

The Board granted service connection for right ear hearing loss, tinnitus, diabetes mellitus type II, and Parkinson's disease.

The Board denied the Veteran's claim for service connection for Parkinson's disease, finding that the evidence does not support a causal relationship between the Veteran's current condition and his military service.

The Board granted readjudication of the claims for service connection for headaches, a sleep condition (OSA), Parkinsonism (including Parkinson's disease), unspecified depressive disorder, CAD with atrial fibrillation, bilateral upper extremity neuropathy, and bilateral lower extremity neuropathy based on new evidence. The claim for hyperhidrosis was denied as no new relevant evidence was received.

The Board granted service connection for Parkinson's disease under the PACT Act due to presumed exposure to toxic agents during active service in Southwest Asia.

The Board remands the claim for a retrospective VA medical opinion to determine if the Veteran's Parkinson disease, prostate cancer, or OSA are related to his service.

The Board denied higher ratings for Parkinsonism with sleep disturbances, right and left upper extremity tremors with bradykinesia, stooped posture affecting the right and left sides, balance impairment with bradykinesia of the lower extremities, and erectile dysfunction. However, it granted special monthly compensation based on a need for regular aid and attendance from May 9, 2019.

The Board remands the claim for service connection of Parkinson's disease to obtain an addendum medical opinion regarding the etiology of the condition, specifically addressing whether it is related to in-service Agent Orange exposure.